Showing results (61-70 of 93) with videos related to
Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199Sylvia Adams, Robert J Gray, Sandra Demaria, et al.The New England Journal of Medicine|October 23, 2018
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast CancerPeter Schmid, Sylvia Adams, Hope S Rugo, et al.NPJ Breast Cancer|November 9, 2019
If we build it they will come: targeting the immune response to breast cancerMargaret E Gatti-Mays, Justin M Balko, Sofia R Gameiro, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2019
Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled AnalysisMelinda L Telli, Charles Chu, Sunil S Badve, et al.Proceedings of the National Academy of Sciences of the United States of America|May 23, 2007
Vaccination with NY-ESO-1 protein and CpG in Montanide induces integrated antibody/Th1 responses and CD8 T cells through cross-primingDanila Valmori, Naira E Souleimanian, Valeria Tosello, et al.American Journal of Cancer Research|July 25, 2014
Distinct breast cancer subtypes in women with early-onset disease across racesMandeep Singh, Yi Ding, Li-Ying Zhang, et al.Journal of Neuro-Oncology|April 17, 2024
Improved outcomes for triple negative breast cancer brain metastases patients after stereotactic radiosurgery and new systemic approachesElad Mashiach, Juan Diego Alzate, Fernando De Nigris Vasconcellos, et al.Journal for Immunotherapy of Cancer|August 14, 2021
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of breast cancerLeisha A Emens, Sylvia Adams, Ashley Cimino-Mathews, et al.JAMA Oncology|June 27, 2024
Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With ChemotherapyVeerle C M Geurts, Sara Balduzzi, Tessa G Steenbruggen, et al.The Oncologist|May 31, 2022
Outcomes of Breast Cancer Patients Treated with Chemotherapy, Biologic Therapy, Endocrine Therapy, or Active Surveillance During the COVID-19 PandemicDouglas K Marks, Nibash Budhathoki, John Kucharczyk, et al.Pageof 10